Johnson & Johnson Price to Free Cash Flow Ratio 2006-2021 | JNJ
Historical price to free cash flow ratio values for Johnson & Johnson (JNJ) since 2006.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Johnson & Johnson Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2021-09-17 |
164.75 |
|
18.79 |
| 2021-06-30 |
163.76 |
$8.77 |
18.67 |
| 2021-03-31 |
162.37 |
$8.14 |
19.95 |
| 2020-12-31 |
154.52 |
$7.67 |
20.14 |
| 2020-09-30 |
145.15 |
$6.91 |
21.01 |
| 2020-06-30 |
136.20 |
$6.65 |
20.49 |
| 2020-03-31 |
126.12 |
$8.50 |
14.83 |
| 2019-12-31 |
139.39 |
$8.64 |
16.14 |
| 2019-09-30 |
122.78 |
$9.35 |
13.14 |
| 2019-06-30 |
132.18 |
$8.74 |
15.12 |
| 2019-03-31 |
131.76 |
$8.04 |
16.38 |
| 2018-12-31 |
120.84 |
$7.97 |
15.17 |
| 2018-09-30 |
128.56 |
$7.48 |
17.19 |
| 2018-06-30 |
112.15 |
$7.70 |
14.57 |
| 2018-03-31 |
117.58 |
$7.36 |
15.97 |
| 2017-12-31 |
127.38 |
$7.14 |
17.83 |
| 2017-09-30 |
117.81 |
$7.11 |
16.57 |
| 2017-06-30 |
119.12 |
$6.62 |
17.99 |
| 2017-03-31 |
111.41 |
$6.33 |
17.60 |
| 2016-12-31 |
102.39 |
$6.03 |
16.99 |
| 2016-09-30 |
104.26 |
$5.86 |
17.78 |
| 2016-06-30 |
106.35 |
$6.19 |
17.17 |
| 2016-03-31 |
94.20 |
$6.66 |
14.15 |
| 2015-12-31 |
88.79 |
$6.96 |
12.76 |
| 2015-09-30 |
80.10 |
$6.13 |
13.07 |
| 2015-06-30 |
82.98 |
$6.80 |
12.20 |
| 2015-03-31 |
85.03 |
$6.56 |
12.96 |
| 2014-12-31 |
87.77 |
$6.85 |
12.81 |
| 2014-09-30 |
88.89 |
$6.76 |
13.16 |
| 2014-06-30 |
86.66 |
$5.83 |
14.88 |
| 2014-03-31 |
80.81 |
$5.49 |
14.71 |
| 2013-12-31 |
74.80 |
$4.96 |
15.07 |
| 2013-09-30 |
70.31 |
$4.94 |
14.25 |
| 2013-06-30 |
69.13 |
$4.71 |
14.67 |
| 2013-03-31 |
65.15 |
$4.64 |
14.04 |
| 2012-12-31 |
55.57 |
$4.97 |
11.19 |
| 2012-09-30 |
54.15 |
$5.02 |
10.79 |
| 2012-06-30 |
52.61 |
$5.05 |
10.42 |
| 2012-03-31 |
50.88 |
$4.83 |
10.54 |
| 2011-12-31 |
50.14 |
$4.59 |
10.92 |
| 2011-09-30 |
48.25 |
$4.62 |
10.43 |
| 2011-06-30 |
49.95 |
$4.71 |
10.61 |
| 2011-03-31 |
44.10 |
$4.72 |
9.35 |
| 2010-12-31 |
45.63 |
$5.21 |
8.76 |
| 2010-09-30 |
45.32 |
$5.76 |
7.87 |
| 2010-06-30 |
42.79 |
$5.69 |
7.52 |
| 2010-03-31 |
46.81 |
$5.50 |
8.51 |
| 2009-12-31 |
45.89 |
$5.15 |
8.91 |
| 2009-09-30 |
43.05 |
$4.77 |
9.03 |
| 2009-06-30 |
39.84 |
$4.60 |
8.66 |
| 2009-03-31 |
36.56 |
$4.36 |
8.38 |
| 2008-12-31 |
41.24 |
$4.48 |
9.22 |
| 2008-09-30 |
47.38 |
$4.28 |
11.08 |
| 2008-06-30 |
43.72 |
$4.03 |
10.85 |
| 2008-03-31 |
43.78 |
$4.05 |
10.81 |
| 2007-12-31 |
44.72 |
$4.31 |
10.38 |
| 2007-09-30 |
43.78 |
$4.49 |
9.76 |
| 2007-06-30 |
40.78 |
$4.49 |
9.08 |
| 2007-03-31 |
39.62 |
$4.30 |
9.20 |
| 2006-12-31 |
43.16 |
$4.08 |
10.57 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$434.939B |
$82.584B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
